Atwater Malick’s Amgen AMGN Stock Holding History

Atwater Malick’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$233K	Buy	+644	New	+$220K	0.05%	112
2019 Q4	–	Sell	-200	Closed	-$39K	–	44
2019 Q3	$39K	Buy	+200	New	+$38.4K	0.03%	80

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Atwater Malick's AMGN Position: Q2 2026 in Review

Atwater Malick opened a new position in Amgen (AMGN) in Q2 2026: 644 shares worth $233K. The stake represents 0.05% of the portfolio and ranks #112 among its holdings. This is a return to the name: Atwater Malick previously reported a position in AMGN as recently as Q3 2019.

Atwater Malick first reported a position in AMGN in Q3 2019 and has held it in 2 quarters since. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Atwater Malick held 644 shares of Amgen worth $233K as of Q2 2026.
Amgen was a new Atwater Malick position in Q2 2026.
Amgen made up 0.05% of Atwater Malick's portfolio in Q2 2026, its #112 holding.
Atwater Malick first reported a position in Amgen in Q3 2019 and has held it in 2 quarters since.
3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Atwater Malick's 13F filing for Q2 2026, filed 27 Jul 2026.